Union Pharmaceutical is a market-oriented, innovative high-tech pharmaceutical enterprise that realizes industrial development through R&D innovation and technology transformation.

　　From scientific experiments, lab-scale research and development, to pilot scale up and commercialized production, we have always respected the development concept of science and technology to create value, and realized the rapid transformation of science and technology into social productive forces; From a team of scientists to a group of industrial engineering experts, from quality analysis to standard the quality assurance system; From EHS system to digital management of key production posts, we pay great importance to the overall development of talents, innovation, environment, health, safety and economic benefits; The company enhances the contribution of digital technology to the development and growth of the company by establishing w multi-platform digital operation management system. Union pharmaceutical is growing in the transformation and developing in adversity by abiding the concept of integrity, innovation, sharing and win-win.

　　The Company's current and future development goals cover the following sectors:

　　1) Pharmaceutical R&D;

　　2) Production of advanced intermediates and APIs in line with GMP quality system;

　　3) API quality research and preparation research and development;

　　4) Sales of pharmaceutical intermediates and APIs;

　　5) CDMO service;

　　6) Intelligent medical research and development

　　The company integrates multiple resources and strives to build a large health industry finance platform company integrating pharmaceutical, intelligent medical, bio pharmaceutical R&D, industrial production and sales.

　　The chemical reactions involved in the existing products include Foucault reaction, nitration reaction, sulfonation reaction, hydrogenation reaction, fluorination reaction, chlorination reaction, bromination reaction, diazotization reaction, format reaction, etc.

　　The company plans to establish a synthetic biology R&D center and a micro chemical process development engineering research center.

　　Union has its own intermediates managed according to the GMP system, API manufacturing plants, and CDMO business. He hopes to carry out and strengthen cooperation with relevant partners in various fields and contribute to safeguarding human health.

　　Union Medicine has also been deeply engaged in the field of small molecule nucleoside nucleic acid drugs for many years, with certain accumulation. With the development and application of artificial intelligence and big data, it is actively accelerating the layout of high-end characteristic APIs, preparing for the development of relevant preparation varieties, and also laying a solid foundation for the subsequent innovative drug research and development.